Edition:
India

People: Adial Pharmaceuticals Inc (ADIL.OQ)

ADIL.OQ on NASDAQ Stock Exchange Capital Market

1.32USD
18 Sep 2020
Change (% chg)

$0.02 (+1.54%)
Prev Close
$1.30
Open
$1.30
Day's High
$1.38
Day's Low
$1.30
Volume
31,603
Avg. Vol
116,880
52-wk High
$3.16
52-wk Low
$1.00

Schuyler, Kevin 

Mr. Kevin Schuyler serves as Vice Chairman, Lead Independent Director of the Company. He currently serves as a senior managing director at CornerStone Partners LLC, a full-service institutional CIO and investment office located in Charlottesville, VA, with approximately $10 billion under management. Prior to joining CornerStone Partners in 2006, he was chief investment officer, vice president, and director of finance and investments for The Nature Conservancy, the world’s largest not-for-profit conservation organization where he oversaw a billion-dollar investment portfolio. Before The Nature Conservancy, he was a management consultant with McKinsey & Company, and an entrepreneur, and a commodities merchant for Louis Dreyfus Corporation. Mr. Schuyler serves on various boards and committees of Sentara Martha Jefferson Hospital, the US Endowment for Forestry and Communities, and Stone Barns Center. He is a member of the investment committee of the Margaret A. Cargill Philanthropies. Mr. Schuyler graduated with honors from Harvard College and received his MBA from The Darden Graduate School of Business at the University of Virginia. He is a member of the Chartered Financial Analyst Society of Washington, DC.

Basic Compensation

Total Annual Compensation, USD 35,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 35,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --